Effects of a thromboxane synthetase inhibitor and a thromboaxane antagonist on release and activity of thromboxane A2 and prostaglandin in vitro
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 29 (5) , 785-797
- https://doi.org/10.1016/0090-6980(85)90138-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- RCS from human platelets: Is it only thromboxane?European Journal of Pharmacology, 1983
- UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activityThrombosis Research, 1981
- Rat aortic strip as a bioassay tissue for thromboxane A2 and rabbit aorta contracting substance (RCS) released from guinea pig lung by bradykinin or anaphylaxisProstaglandins, 1979
- PHOSPHOLIPASE A2 ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDSBritish Journal of Pharmacology, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea‐pig lungsBritish Journal of Pharmacology, 1973
- Prostaglandins, oxygen tension and smooth muscle toneBritish Journal of Pharmacology, 1972
- Interference of some thiol derivatives with the pharmacological effects of arachidonic acid and Slow Reacting Substance C amd with the release of Rabbit Aorta Contracting substancesEuropean Journal of Pharmacology, 1972
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory DrugsNature, 1969
- Multiple Range and Multiple F TestsPublished by JSTOR ,1955